As aggregate interest increased, key money managers were leading the bulls’ herd. Tourbillon Capital Partners, led by Jason Karp, assembled the most outsized position in Sarepta Therapeutics Inc (NASDAQ:SRPT). Tourbillon Capital Partners had $105.2 million invested in the company at the end of the quarter. Jeremy Green’s Redmile Group also made a $39.3 million investment in the stock during the quarter. The following funds were also among the new SRPT investors: Samuel Isaly’s OrbiMed Advisors, and Paul Tudor Jones’s Tudor Investment Corp.
Let’s now review hedge fund activity in other stocks similar to Sarepta Therapeutics Inc (NASDAQ:SRPT). These stocks are Air Lease Corp (NYSE:AL), Vector Group Ltd (NYSE:VGR), Masimo Corporation (NASDAQ:MASI), and Home Bancshares Inc (NASDAQ:HOMB). All of these stocks’ market caps are similar to SRPT’s market cap.
|Ticker||No of HFs with positions||Total Value of HF Positions (x1000)||Change in HF Position|
As you can see these stocks had an average of 19 hedge funds with bullish positions and the average amount invested in these stocks was $162 million. That figure was $1.12 billion in SRPT’s case. Air Lease Corp (NYSE:AL) is the most popular stock in this table. On the other hand Home Bancshares Inc (NASDAQ:HOMB) is the least popular one with only 9 bullish hedge fund positions. Compared to these stocks Sarepta Therapeutics Inc (NASDAQ:SRPT) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.